Recruiting Kidney Cancer Studies in Orange
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherap...
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
This phase II trial tests whether using genetic testing of tumor tissue to select the optimal treatment regimen works in treating patients with clear cell renal cell (kidney) cancer that has spread to...
About Kidney Cancer Clinical Trials in Orange
Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.
There are currently 2 kidney cancer clinical trials recruiting participants in Orange, CT. These studies are seeking a combined 294 participants. Research is being sponsored by NRG Oncology, Vanderbilt-Ingram Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Kidney Cancer Clinical Trials in Orange — FAQ
Are there kidney cancer clinical trials in Orange?
Yes, there are 2 kidney cancer clinical trials currently recruiting in Orange, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Orange?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.
Are clinical trials in Orange free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.
What kidney cancer treatments are being tested?
The 2 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.
Data updated March 2, 2026 from ClinicalTrials.gov